TNFSF13B and plasma cell myeloma: We have previously demonstrated BAFF-induced chemoprotection in multiple other B-cell cancer models, including acute lymphoblastic leukemia and mantle cell lymphoma, and other groups have also shown this effect in myeloma and chronic lymphocytic leukemia models [26,27,28,29,62].